A patient with acute schizophrenia is receiving antipsychotic monotherapy, and you are considering how dose changes may relate to positive and negative symptom improvement. A colleague asks what this systematic review and dose-response meta-analysis supports.
Which statement is best supported by the evidence in this abstract?